Cytoreductive Surgery plus Hyperthermic Intraperitoneal Chemotherapy Improves Survival with Acceptable Safety for Advanced Ovarian Cancer: A Clinical Study of 100 Patients

Table 4

Adverse events rate of 100 AOC patients.

Items	, %
SAE (grades III-V)	4 (4.0)
Perioperative mortality	2 (2.0)
Blood loss	1 (1.0)
Colon leakage	1 (1.0)
AE (grades I-II)	27 (27.0)
Anemia and hypoproteinemia	5 (5.0)
Urinary fistula	4 (4.0)
Ileus	4 (4.0)
Respiratory infection	4 (4.0)
DVT	3 (3.0)
Wound infection	3 (3.0)
Renal dysfunction	2 (2.0)
Urinary tract infection	2 (2.0)

AE: adverse event; SAE: serious adverse event; DVT: deep venous thrombosis.